Treatment of seizures in the neurologic intensive care unit

Current Treatment Options in Neurology

Volumn 9, Issue 2, 2007, Pages 136-145

  Varelas, Panayiotis N ^a   Mirski, Marek ^b  

^a HENRY FORD HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; AMPHETAMINE; ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIVIRUS AGENT; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; BRONCHODILATING AGENT; CARBAMAZEPINE; COCAINE; DIAZEPAM; ETIRACETAM; FOSPHENYTOIN SODIUM; GABAPENTIN; IMMUNOSUPPRESSIVE AGENT; LAMOTRIGINE; LOCAL ANESTHETIC AGENT; LORAZEPAM; MIDAZOLAM; NEUROLEPTIC AGENT; OPIATE; OXCARBAZEPINE; PENICILLIN DERIVATIVE; PHENCYCLIDINE; PHENYTOIN; TOPIRAMATE; UNINDEXED DRUG; VALPROIC ACID; ZONISAMIDE;

ALGORITHM; BRAIN HEMORRHAGE; BRAIN INJURY; BRAIN TUMOR; BRAIN VEIN; CEREBRAL SINUS THROMBOSIS; CEREBROVASCULAR ACCIDENT; CORRELATION ANALYSIS; DISORDERS OF CARBOHYDRATE METABOLISM; DRUG BLOOD LEVEL; DRUG CLEARANCE; ELECTROENCEPHALOGRAPHY; ELECTROLYTE DISTURBANCE; EPILEPSY; EPILEPTIC STATE; HUMAN; HYPONATREMIA; INTENSIVE CARE; INTENSIVE CARE UNIT; LOADING DRUG DOSE; METABOLIC DISORDER; MONOTHERAPY; PATIENT MONITORING; REPERFUSION INJURY; REVIEW; RISK FACTOR; SEIZURE; STAFF TRAINING; STROKE; SUBARACHNOID HEMORRHAGE; TREATMENT PLANNING; VEIN THROMBOSIS;

EID: 33847632976     PISSN: 10928480     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11940-007-0039-9     Document Type: Review

References (90)

1. Varelas PN, Mirski MA: Seizures in the adult intensive care unit. J Neurosurg Anesthesiol 2001, 13:163-175.
2. Varelas PN: Seizures in Critical Care: A Guide to Diagnosis and Therapeutics. Totowa, NJ: Humana Press; 2004.
3. Varelas PN, Hacein-Bey L, Hether T, et al.: Emergent electroencephalogram in the intensive care unit: indications and diagnostic yield. Clin EEG Neurosci 2004, 35:173-180.
4. Jordan KG: Continuous EEG monitoring in the neuroscience intensive care unit and emergency department. J Clin Neurophysiol 1999, 16:14-39.
5. Wallace KL: Antibiotic-induced convulsions. Crit Care Clin 1997, 13:741-762.
6. Somjen GG: Ion regulation in the brain: implications for pathophysiology. Neuroscientist 2002, 8:254-267.
7. Hauser WA, Kurland LT: The epidemiology of epilepsy in Rochester, Minnesota, 1935 through 1967. Epilepsia 1975, 16:1-66.
8. Bladin CF, Alexandrov AV, Bellavance A, et al.: Seizures after stroke: a prospective multicenter study. Arch Neurol 2000, 57:1617-1622.
9. Arboix A, Comes E, Massons J, et al.: Relevance of early seizures for in-hospital mortality in acute cerebrovascular disease. Neurology 1996, 47:1429-1435.
10. Reith J, Jorgensen HS, Nakayama H, et al.: Seizures in acute stroke: predictors and prognostic significance. The Copenhagen Stroke Study. Stroke 1997, 28:1585-1589.
11. Sun DA, Sombati S, DeLorenzo RJ: Glutamate injury-induced epileptogenesis in hippocampal neurons: an in vitro model of stroke-induced "epilepsy." Stroke 2001, 32:2344-2350.
12. Lancman ME, Golimstok A, Norscini J, Granillo R: Risk factors for developing seizures after a stroke. Epilepsia 1993, 34:141-143.
13. Lamy C, Domigo V, Semah F, et al.: Early and late seizures after cryptogenic ischemic stroke in young adults. Neurology 2003, 60:400-404.
14. Berges S, Moulin T, Berger E, et al.: Seizures and epilepsy following strokes: recurrence factors. Eur Neurol 2000, 43:3-8.
15. Cleary P, Shorvon S, Tallis R: Late-onset seizures as a predictor of subsequent stroke. Lancet 2004, 363:1184-1186.
16. Rumbach L, Sablot D, Berger E, et al.: Status epilepticus in stroke: report on a hospital-based stroke cohort. Neurology 2000, 54:350-354.
17. Adams HP Jr, Adams RJ, Brott T, et al.: Guidelines for the early management of patients with ischemic stroke: a scientific statement from the Stroke Council of the American Stroke Association. Stroke 2003, 34:1056-1083.
18. Gilad R, Lampl Y, Eschel Y, Sadeh M: Antiepileptic treatment in patients with early postischemic stroke seizures: a retrospective study. Cerebrovasc Dis 2001, 12:39-43.
19. Cordonnier C, Henon H, Derambure P, et al.: Influence of pre-existing dementia on the risk of post-stroke epileptic seizures. J Neurol Neurosurg Psychiatry 2005, 76:1649-1653.
20. Leker RR, Neufeld MY: Anti-epileptic drugs as possible neuroprotectants in cerebral ischemia. Brain Res Brain Res Rev 2003, 42:187-203.
21. Goldstein LB: Potential effects of common drugs on stroke recovery. Arch Neurol 1998, 55:454-456.
22. Alvarez-Sabin J, Montaner J, Padro L, et al.: Gabapentin in late-onset poststroke seizures. Neurology 2002, 59:1991-1993.
23. Giroud M, Gras P, Fayolle H, et al.: Early seizures after acute stroke: a study of 1,640 cases. Epilepsia 1994, 35:959-964.
24. Vespa PM, O'Phelan K, Shah M, et al.: Acute seizures after intracerebral hemorrhage: a factor in progressive midline shift and outcome. Neurology 2003, 60:1441-1446.
25. Faught E, Peters D, Bartolucci A, et al.: Seizures after primary intracerebral hemorrhage. Neurology 1989, 39:1089-1093.
26. Tatu L, Moulin T, El Mohamad R, et al.: Primary intracerebral hemorrhages in the Besancon stroke registry. Initial clinical and CT findings, early course and 30-day outcome in 350 patients. Eur Neurol 2000, 43:209-214.
27. Broderick JP, Adams HP Jr, Barsan W, et al.: Guidelines for the management of spontaneous intracerebral hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 1999, 30:905-915.
28. Berger AR, Lipton RB, Lesser ML, et al.: Early seizures following intracerebral hemorrhage: implications for therapy. Neurology 1988, 38:1363-1365.
29. Passero S, Rocchi R, Rossi S, et al.: Seizures after spontaneous supratentorial intracerebral hemorrhage. Epilepsia 2002, 43:1175-1180.
30. Cervoni L, Artico M, Salvati M, et al.: Epileptic seizures in intracerebral hemorrhage: a clinical and prognostic study of 55 cases. Neurosurg Rev 1994, 17:185-188.
31. Qureshi AI, Tuhrim.S, Broderick JP, et al.: Spontaneous intracerebral hemorrhage. N Engl J Med 2001, 344:1450-1460.
32. Haines SJ: Decerebrate posturing misinterpreted as seizure activity. Am J Emerg Med 1988, 6:173-177.
33. Pinto AN, Canhao P, Ferro JM: Seizures at the onset of subarachnoid haemorrhage. J Neurol 1996, 243:161-164.
34. Hasan D, Schonck RS, Avezaat CJ, et al.: Epileptic seizures after subarachnoid hemorrhage. Ann Neurol 1993, 33:286-291.
35. Butzkueven H, Evans AH, Pitman A, et al.: Onset seizures independently predict poor outcome after subarachnoid hemorrhage. Neurology 2000, 55:1315-1320.
36. Hart RG, Byer JA, Slaughter JR, et al.: Occurrence and implications of seizures in subarachnoid hemorrhage due to ruptured intracranial aneurysms. Neurosurgery 1981, 8:417-421.
37. Dennis LJ, Claassen J, Hirsch LJ, et al.: Nonconvulsive status epilepticus after subarachnoid hemorrhage. Neurosurgery 2002, 51:1136-1143; discussion 1144.
38. Naval NS, Stevens RD, Mirski MA, Bhardwaj A: Controversies in the management of aneurysmal subarachnoid hemorrhage. Crit Care Med 2006, 34:511-524.
39. Rhoney DH, Tipps LB, Murry KR, et al.: Anticonvulsant prophylaxis and timing of seizures after aneurysmal subarachnoid hemorrhage. Neurology 2000, 55:258-265.
40. Rosengart AJ, Novakovic R, Dezheng H, et al.: Impact of prophylactic anticonvulsive use on outcome in subarachnoid hemorrhage. Stroke 2004, 35:250.
41. Naidech AM, Kreiter KT, Janjua N, et al.: Phenytoin exposure is associated with functional and cognitive disability after subarachnoid hemorrhage. Stroke 2005, 36:583-587.
42. Lin CL, Dumont AS, Lieu AS, et al.: Characterization of perioperative seizures and epilepsy following aneurysmal subarachnoid hemorrhage. J Neurosurg 2003, 99:978-985.
43. Claassen J, Peery S, Kreiter KT, et al.: Predictors and clinical impact of epilepsy after subarachnoid hemorrhage. Neurology 2003, 60:208-214.
44. Baker CJ, Prestigiacomo CJ, Solomon RA: Short-term perioperative anticonvulsant prophylaxis for the surgical treatment of low-risk patients with intracranial aneurysms. Neurosurgery 1995, 37:863-870; discussion 870-871.
45. Byrne JV, Boardman P, Ioannidis I, et al.: Seizures after aneurysmal subarachnoid hemorrhage treated with coil embolization. Neurosurgery 2003, 52:545-552; discussion 550-552.
46. Molyneux AJ, Kerr RS, Yu LM, et al.: International Subarachnoid Aneurysm Trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised comparison of effects on survival, dependency, seizures, rebleeding, subgroups, and aneurysm occlusion. Lancet 2005, 366:809-817.
47. Masuhr F, Busch M, Amberger N, et al.: Risk and predictors of early epileptic seizures in acute cerebral venous and sinus thrombosis. Eur J Neurol 2006, 13:852-856.
48. Ferro JM, Correia M, Rosas MJ, et al.: Seizures in cerebral vein and dural sinus thrombosis. Cerebrovasc Dis 2003, 15:78-83.
49. Coutts SB, Hill MD, Hu WY: Hyperperfusion syndrome: toward a stricter definition. Neurosurgery 2003, 53:1053-1058; discussion 1058-1060.
50. Breen JC, Caplan LR, DeWitt LD, et al.: Brain edema after carotid surgery. Neurology 1996, 46:175-181.
51. Jorgensen LG, Schroeder TV: Defective cerebrovascular autoregulation after carotid endarterectomy. Eur J Vasc Surg 1993, 7:370-379.
52. Ho DS, Wang Y, Chui M, et al.: Epileptic seizures attributed to cerebral hyperperfusion after percutaneous transluminal angioplasty and stenting of the internal carotid artery. Cerebrovasc Dis 2000, 10:374-379.
53. Kieburtz K, Ricotta JJ, Moxley RT 3rd: Seizures following carotid endarterectomy. Arch Neurol 1990, 47:568-570.
54. Salazar AM, Jabbari B, Vance SC, et al.: Epilepsy after penetrating head injury. I. Clinical correlates: a report of the Vietnam Head Injury Study. Neurology 1985, 35:1406-1414.
55. Lee ST, Lui TN, Wong CW, et al.: Early seizures after moderate closed head injury. Acta Neurochir (Wien) 1995, 137:151-154.
56. Vespa PM, Nuwer MR, Nenov V, et al.: Increased incidence and impact of nonconvulsive and convulsive seizures after traumatic brain injury as detected by continuous electroencephalographic monitoring. J Neurosurg 1999, 91:750-760.
57. Frey LC: Epidemiology of posttraumatic epilepsy: a critical review. Epilepsia 2003, 44(Suppl 10):11-17.
58. Temkin NR: Risk factors for posttraumatic seizures in adults. Epilepsia 2003, 44(Suppl 10):18-20.
59. Wiedemayer H, Triesch K, Schafer H, Stolke D: Early seizures following non-penetrating traumatic brain injury in adults: risk factors and clinical significance. Brain Inj 2002, 16:323-330.
60. Chang BS, Lowenstein DH: Practice parameter: antiepileptic drug prophylaxis in severe traumatic brain injury: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2003, 60:10-16.
61. The Brain Trauma Foundation. The American Association of Neurological Surgeons. The Joint Section on Neurotrauma and Critical Care. Role of antiseizure prophylaxis following head injury. J Neurotrauma 2000, 17:549-553.
62. Watson NF, Barber JK, Doherty MJ, et al.: Does glucocorticoid administration prevent late seizures after head injury? Epilepsia 2004, 45:690-694.
63. Temkin NR, Dikmen SS, Anderson GD, et al.: Valproate therapy for prevention of posttraumatic seizures: a randomized trial. J Neurosurg 1999, 91:593-600.
64. Le Blanc FE, Rasmussen T: Cerebral seizures and brain tumors. In Handbook of Clinical Neurology. Edited by Magnus 0, de Haas AML, Vinken PJ, Bruyn GW. Amsterdam: North-Holland Publishing; 1974:295-301.
65. Sirven JI, Wingerchuk DM, Drazkowski JF, et al.: Seizure prophylaxis in patients with brain tumors: a meta-analysis. Mayo Clin Proc 2004, 79:1489-1494.
66. Aguiar D, Pazo R, Duran I, et al.: Toxic epidermal necrolysis in patients receiving anticonvulsants and cranial irradiation: a risk to consider. J Neurooncol 2004, 66:345-350.
67. Glantz MJ, Cole BF, Forsyth PA, et al.: Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors. Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2000, 54:1886-1893.
68. Boswell MV, Wolfe JR: Intrathecal cefazolin-induced seizures following attempted discography. Pain Physician 2004, 7:103-106.
69. Schuele SU, Kellinghaus C, Shook SJ, et al.: Incidence of seizures in patients with multiple sclerosis treated with intrathecal baclofen. Neurology 2005, 64:1086-1087.
70. Yeh HM, Lau HP, Lin PL, et al.: Convulsions and refractory ventricular fibrillation after intrathecal injection of a massive dose of tranexamic acid. Anesthesiology 2003, 98:270-272.
71. Wijdicks EF, Sharbrough FW: New-onset seizures in critically ill patients. Neurology 1993, 43:1042-1044.
72. Armstrong PJ, Bersten A: Normeperidine toxicity. Anesth Analg 1986, 65:536-538.
73. Osorio I, Reed RC, Peltzer JN: Refractory idiopathic absence status epilepticus: a probable paradoxical effect of phenytoin and carbamazepine. Epilepsia 2000, 41:887-894.
74. Spiller HA, Carlisle RD: Status epilepticus after massive carbamazepine overdose. J Toxicol Clin Toxicol 2002, 40:81-90.
75. Cluitmans FH, Meinders AE: Management of severe hyponatremia: rapid or slow correction? Am J Med 1990, 88:161-166.
76. Soupart A, Decaux G: Therapeutic recommendations for management of severe hyponatremia: current concepts on pathogenesis and prevention of neurologic complications. Clin Nephrol 1996, 46:149-169.
77. Van den Berghe G, Schoonheydt K, Becx P, et al.: Insulin therapy protects the central and peripheral nervous system of intensive care patients. Neurology 2005, 64:1348-1353.
78. Hennis A, Corbin D, Fraser H: Focal seizures and non-ketotic hyperglycaemia. J Neurol Neurosurg Psychiatry 1992, 55:195-197.
79. Towne AR, Pellock JM, Ko D, DeLorenzo RJ: Determinants of mortality in status epilepticus. Epilepsia 1994, 35:27-34.
80. Mayer SA, Claassen J, Lokin J, et al.: Refractory status epilepticus: frequency, risk factors, and impact on outcome. Arch Neurol 2002, 59:205-210.
81. Pandey CK, Singh N, Bose N, Sahay S: Gabapentin and propofol for treatment of status epilepticus in acute intermittent porphyria. J Postgrad Med 2003, 49:285.
82. Trinka E, Dilitz E, Unterberger I, et al.: Nonconvulsive status epilepticus after replacement of valproate with lamotrigine. J Neurol 2002, 249:1417-1422.
83. Guerrini R, Belmonte A, Parmeggiani L, Perucca E: Myoclonic status epilepticus following high-dosage lamotrigine therapy. Brain Dev 1999, 21:420-424.
84. Towne AR, Garnett LK, Waterhouse EJ, et al.: The use of topiramate in refractory status epilepticus. Neurology 2003, 60:332-334.
85. Tarulli A, Drislane FW: The use of topiramate in refractory status epilepticus. Neurology 2004, 62:837.
86. Yoshimura I, Kaneko S, Yoshimura N, Murakami T: Long-term observations of two siblings with Lafora disease treated with zonisamide. Epilepsy Res 2001, 46:283-287.
87. Gaida-Hommernick B, Rieck K, Runge U: Oxcarbazepine in focal epilepsy and hepatic porphyria: a case report. Epilepsia 2001, 42:793-795.
88. Rossetti AO, Bromfield EB: Determinants of success in the use of oral levetiracetam in status epilepticus. Epilepsy Behav 2006, 8:651-654.
89. Patel NC, Landan IR, Levin J, et al.: The use of levetiracetam in refractory status epilepticus. Seizure 2006, 15:137-141.
90. Zaatreh MM: Levetiracetam in porphyric status epilepticus: a case report. Clin Neuropharmacol 2005, 28:243-244.